Overcoming the response plateau in multiple myeloma: A novel bortezomib-based strategy for secondary induction and high-yield CD34+ stem cell mobilization Academic Article uri icon

Overview

MeSH Major

  • Boronic Acids
  • Dexamethasone
  • Multiple Myeloma
  • Neoplastic Stem Cells
  • Pyrazines

abstract

  • Bortezomib-based secondary induction and mobilization could represent an alternative strategy for elimination of tumor burden in immunomodulatory drug-resistant patients that does not impact stem cell yield.

publication date

  • March 15, 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4020015

Digital Object Identifier (DOI)

  • 10.1158/1078-0432.CCR-12-1429

PubMed ID

  • 23357980

Additional Document Info

start page

  • 1534

end page

  • 46

volume

  • 19

number

  • 6